Cooling Anesthesia for Intravitreal Injection: Results of the Prospective Open-Label, Dose-Ranging COOL-1 Trial.

Daniel L ChaoNicolas T RinellaArshad M KhananiCharles C WykoffGun-Ho Kim

Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)

The rapid cooling anesthesia device was well tolerated for achieving local anesthesia among patients receiving intravitreal injections with no serious ocular adverse events.

Keyphrases

open label
vascular endothelial growth factor
phase iii
clinical trial
phase ii
study protocol
diabetic retinopathy
age related macular degeneration
ultrasound guided
squamous cell carcinoma
endothelial cells
sensitive detection
placebo controlled
cataract surgery